Risk factors for severe sepsis in community-onset bacteraemic urinary tract infection: Impact of antimicrobial resistance in a large hospitalised cohort

Journal of Infection

Volumn 70, Issue 3, 2015, Pages 247-254

  Shaw, Evelyn ^a   Benito, Natividad ^b   Rodríguez Baño, Jesús ^c   Padilla, Belén ^d   Pintado, Vicente ^e   Calbo, Esther ^f   Pallarés, MaAngeles ^g   Gozalo, Mónica ^h   Ruiz Garbajosa, Patricia ^e   Horcajada, Juan Pablo ⁱ   Gomez J ⁱ   Cercenado, E ^d   Bunshow, E ^d   Sanchez Carrillo C ^d   Xercavins, M ^j   Riera, M M ^j   Mirelis, B ^b   Gamallo, R ^k   Martinez, L ^h   Farinas M C ^h   de Cueto, M ^c   Pascual, A ^c   more..

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

^g Hospital Nuestra Señora de Candelaria Sta Cruz de Tenerife   (Spain)

^h HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

ⁱ HOSPITAL DEL MAR   (Spain)

^j HOSPITAL MÚTUA DE TERRASSA   (Spain)

^k Hospital Gregorio Marañón ^*  (Spain)

more..

Author keywords

Bacteraemia; Multidrug resistance; Risk factors; Severe sepsis or septic shock; Urinary tract infection

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; GENTAMICIN; HOST FACTOR; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SEPSIS; SEPTICEMIA; SPAIN; TERTIARY CARE CENTER; URETHRAL CATHETER; URINARY TRACT INFECTION; VERY ELDERLY; ADVERSE EFFECTS; CROSS INFECTION; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; FEMALE; INDWELLING CATHETER; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; SEPTIC SHOCK; TIME; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERS, INDWELLING; COHORT STUDIES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; SHOCK, SEPTIC; SPAIN; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 84922928912     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.09.011     Document Type: Article

References (31)

1. Hounsom L., Grayson K., Melzer M. Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemia. Postgrad Med J 2011, 87:757-762.
2. Rodríguez F., Barrera L., De la Rosa G., Dennis R., Dueñas G., Granados M., et al. The epidemiology of sepsis in Colombia: a prospective multicenter cohort study in ten university hospitals. Crit Care Med 2011, 39:1675-1682.
3. Rodriguez-Baño J., López-Prieto M.D., Portillo M.M., Retamar P., Natera C., Nuño E., et al. Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals. Clin Microbiol Infect 2010, 16:1408-1413.
4. Hsu C.Y., Fang H.C., Chou K.J., Chen C.L., Lee P.T., Chung H.M. The clinical impact of bacteremia in complicated acute pyelonephritis. Am J Med Sci 2006, 332:175-180.
5. Lee J.H., Lee Y.M., Cho J.H. Risk factors of septic shock in bacteremic acute pyelonephritis patients admitted to an ER. J Infect Chemother 2012, 18:130-133.
6. Yamamoto Y., Fujita K., Nakazawa S., Hayashi T., Tanigawa G., Imamura R., et al. Clinical characteristics and risk factors for septic shock in patients receiving emergency drainage for acute pyelonephritis with upper urinary tract calculi. BMC Urol. 2012, 12:4. 10.1186/1471-2490-12-4.
7. Brun-Buisson C., Meshaka P., Pinton P., Vallet B. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004, 30:580-588. EPISEPSIS Study Group.
8. Esteban A., Frutos-Vivar F., Ferguson N.D., Peñuelas O., Lorente J.A., Gordo F., et al. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med 2007, 35:1284-1289.
9. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 2001, 29:1303-1310.
10. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United Stated from 1979 through 2000. N Engl JMed 2003, 348:1546-1554.
11. Johnson J.R., Kuskowski M.A., Gajewski A., Sahm D.F., Karlowski J.A. Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001. J Infect Dis 2004, 190:1739-1744.
12. Horcajada J.P., Soto S., Gajewski A., Smithson A., Jimenez de Anta M.T., Mensa J., et al. Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol 2005, 43:2962-2964.
13. Alós J.I. Epidemiology and etiology of urinary tract infections in the community. Antimicrobial susceptibility of the main pathogens and clinical significance of resistance. Enferm Infecc Microbiol Clin 2005, 23(Suppl. 4):3-8.
14. European Centre for Disease Prevention and Control Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2012, ECDC, Stockholm.
15. Horcajada J.P., Shaw E., Padilla B., Pintado V., Calbo E., Benito N., et al. Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance. Clin Microbiol Infect 2013, 19:962-968.
16. Chow J.W., Yu V.L. Combination antibiotic therapy versus monotherapy for gram-negative bacteremia: a commentary. Int JAntimicrob Agents 1999, 11:7-12.
17. CDC/NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care Setting January, 2014, (last accessed on the 20th of May, 2014). http://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf.
18. Ha Y.E., Kang C.I., Joo E.J., Park S.Y., Kang S.J., Wi Y.M., et al. Clinical implications of healthcare-associated infection in patients with community-onset acute pyelonephritis. Scand J Infect Dis 2011, 43:587-595.
19. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256. SCCM/ESICM/ACCP/ATS/SIS.
20. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock 2012. Crit Care Med 2013, 41:580-637.
21. CLSI Performance standards for antimicrobial susceptibility testing; Nineteenth informational supplement 2009, CLSI document M100-S19, Clinical and Laboratory Standards Institute, Wayne, PA.
22. Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
23. Christoph F., Weikert S., Müller M., Miller K., Schrader M. How septic is urosepsis? Clinical course of infected hydronephrosis and therapeutic strategies. World J Urol 2005, 23:243-247.
24. Wagenlehner F.M., Pilatz A., Weidner W. Urosepsis from the view of the urologist. Int J Antimicrob Agents 2011, 38:51-57.
25. Melekos M.D., Naber K.G. Complicated urinary tract infections. Int J Antimicrob Agents 2000, 15:247-256.
26. Kunin C.K. Urinary-catheter-associated infections in the elderly. Int J Antimicrob Agents 2006, 28S:S78-S81.
27. Jauréguy F., Carbonnelle E., Bonacorsi S., Clec'h C., Casassus P., Bingen E., et al. Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clin Microbiol Infect 2007, 13:854-862.
28. Rodriguez-Baño J., Mingorance J., Fernandez-Romero N., Serrano L., López-Cerero L., Pascual A. Outcome of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli: impact of microbiological determinants. J Infect 2013, 67:27-34.
29. Lefort A., Panhard X., Clermont O., Woerther P.L., Branger C., Mentré F., et al. Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia. J Clin Microbiol 2011, 49:777-783.
30. Al-Hasan M.N., Eckel-Passow J.E., Baddour L.M. Bacteremia complicating gram-negative urinary tract infections: a population-based study. J Infect 2010, 60:278-285.
31. Chin B.S., Kim M.S., Han S.H., Shin S.Y., Choi H.K., Chae Y.T., et al. Risk factors of all cause mortality among Korean elderly bacteremic urinary tract infection (UTI) patients. Arch Gerontol Geriatr 2011, 52:e50-e55.